Spiral TX

formerly Spiral Therapeutics

Spiral TX is a biotech company in South San Francisco, United States, founded in 2016. It has raised $35.3M across 2 rounds, most recently a $27.0M Series B in April 2026.

IMPROVING LIVES BY PROTECTING HEARING

Employees
1–10
Founded
2016
Total Funding
$35.3M
Last Round
$27.0M Series BApr 2026
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 5 investors for this company. The full record is or through the API.

About

Spiral Therapeutics is advancing a therapeutic pipeline focused on balance disorders and hearing loss. Its lead program, SPT-2101, is a sustained-release steroid formulation for the treatment of Ménière's disease, a condition diagnosed in more than 600,000 patients in the United States. The company's MICS (minimally-invasive cochlear system) delivery platform delivers a wide range of drugs to the ear with high precision and long duration in a clinic-friendly approach.

Summary

It lists 1–10 employees. It has raised $35.3M in total across 2 rounds, most recently a $27.0M Series B round in Apr 2026. Investors include Goldman Sachs Alternatives, SoftBank and Nvidia.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series BSeries BApr 2026
$27.0M

Sign up to see all 2 events

Funding: Venture Round through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Paratek PharmaceuticalsAcquired

Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...

Boston, United States201–500Biotech, Healthcare
ConvertibleTotal funding$1.8BApr 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020
Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
Alnylam PharmaceuticalsIPO

Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...

Cambridge, United States1001–5000Biotech, Genomics
Corporate RoundTotal funding$1.0BApr 2020
ArsenalBio

Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...

San Francisco, United States201–500Biotech, Life Sciences
Series CTotal funding$955.0MSep 2024
Lyell ImmunopharmaIPO

Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...

South San Francisco, United States201–500Biotech, Healthcare
Venture RoundTotal funding$884.0MJul 2025

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Spiral TX on Indexed.vc
<a href="https://indexed.vc/companies/spiral-tx"><img src="https://indexed.vc/api/badge/company/spiral-tx" alt="Spiral TX on Indexed.vc" width="260" height="76" /></a>